Blog

2017 Research Drive Kicks Off

Join the 2017 Research Drive to Help #CureAtaxia The Annual Ataxia Research Drive began on October 15 with the challenge to raise $400,000 by December 15 to fund the finest Ataxia research. There were 84 research applications submitted to the National Ataxia Foundation for consideration. They are currently being peer-reviewed Read More…

Print Friendly, PDF & Email
Clinical Trial News

Ataxia Clinical Trial Progresses to 48-Week Extension Phase

BIOHAVEN OPTIMISTIC FOR NEXT PHASE OF TRIAL DESPITE DISAPPOINTING TOPLINE DATA As NAF previously reported, BioHaven Pharmaceutical Holding Company Ltd. recently completed its 8-week trial of dosing for its drug compound trigriluzole. This is the largest clinical trial for Spinocerebellar Ataxia (SCA) to-date. During the 8-week randomization phase, either the compound Read More…

Print Friendly, PDF & Email

Want to be a guest blogger?

Submit your name and blog topic. We’ll follow up with submission instructions.

Print Friendly, PDF & Email
Translate »

Your gift to Ataxia research DOUBLED through December 31st

Contributions to the Annual Research Drive help NAF fund the very best Ataxia research. An anonymous donor will match every dollar donated during this campaign, up to $50,000.

Your donation means more Ataxia research! Thank you for supporting NAF as we seek effective treatments for Ataxia.

Thank you so much!